A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 901–995 of 995
Monogenic and Polygenic Genetic Contributions to Hypertension
Ingelfinger, J. R. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-797-0_12 · Cited by 2
Stölting, G., & Scholl, U. I. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_680 · Cited by 1
Boulkroun, S., & Zennaro, M. (2023) · Endocrinology · doi:10.1007/978-3-030-44628-4_13-1 · Cited by 1
Genetics of Hypertension and Heart Failure
Padmanabhan, S., du Toit, C., & Dominiczak, A. F. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-39315-0_4 · Cited by 1
Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand
Elston, M. S., Tamatea, J. A. U., King, R. I., Florkowski, C. M., & Boyle, V. (2024) · Internal Medicine Journal · doi:10.1111/imj.16511 · Cited by 1
Exome Sequencing as a Diagnostic Tool in Patients With Rare Genetic Syndromes
Zeman, J., Musil, Z., Jenčová, P., Hirschfeldová, K., Flachsová, E., Seeman, T., Musil, V., Zach, P., & Vícha, A. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00371-7 · Cited by 1
Baxdrostat for the treatment of primary aldosteronism: current evidence
Menino, J., Vega, A., Goi, J., & Araujo-Castro, M. (2026) · Endocrine · doi:10.1007/s12020-026-04570-2 · Cited by 1
Germline and somatic genetic drivers of adrenocortical tumours
Bouys, L., & Bertherat, J. Y. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102099 · Cited by 1
Genetics and Primary Aldosteronism: Disease Phenotype and Demographic Implications for Hypertension
Fayad, M., Ismail, D., Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26232 · Cited by 2
Seltene Formen der Hypertonie: Vom Phäochromozytom zur Vaskulitis
Haller, H. G., Limbourg, F. P., Schmidt, B. M., & Menne, J. (2015) · Der Internist · doi:10.1007/s00108-014-3571-1 · Cited by 1
Ionenkanalerkrankungen der Niere und Nebenniere
Beck, B. B., Wollnik, B., & Kömhoff, M. (2013) · Medizinische Genetik · doi:10.1007/s11825-013-0423-7 · Cited by 1
Chapter 18 Clinical genetic issues in stroke
Brenner, D. A., Alberts, M. J., & Amarenco, P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)01918-0 · Cited by 1
Giudice, A. D. (2012) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.s3-007 · Cited by 1
Cytochrome P450 Polymorphisms of Clinical Importance
Rettie, A. E., & Thummel, K. E. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_21 · Cited by 1
Ruiz-Palacios, P. C., Rodríguez-Castellanos, F. E., Mancilla-Urrea, E., Ávila-Casado, M. D. C., Inofuentes-Rivero, M. X., Rodríguez-Illana, F., Fragoso, J. M., & Vargas‐Alarcón, G. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312470579 · Cited by 1
Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics
Mulatero, P., Williams, T. A., Monticone, S., Viola, A., Tizzani, D., Crudo, V. L., Burrello, J., & Veglio, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_1 · Cited by 1
Yagil, C., & Yagil, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00022-2 · Cited by 1
Primary Mineralocorticoid Excess Syndromes and Hypertension
Carey, R. M., & Padia, S. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00107-6 · Cited by 1
Hormones and receptors: fundamental considerations
Funder, J. W. (2011) · doi:10.1093/med/9780199235292.003.1022 · Cited by 1
Familial Hyperaldosteronism Type III
Williams, T. A., Monticone, S., Veglio, F., & Mulatero, P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_8 · Cited by 1
Krishnan, N., & Alpern, R. J. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2022.20.2.6 · Cited by 1
Sasano, H., Nakamura, Y., Moriya, T., & Suzuki, T. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_11 · Cited by 2
Pecori, A., Monticone, S., Losano, I., Cavaglià, G., Pieroni, J., Veglio, F., & Mulatero, P. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_5 · Cited by 1
Mendelian disorders causing hypertension
Samani, N. J., & Tomaszewski, M. (2020) · doi:10.1093/med/9780198746690.003.0380 · Cited by 1
Economopoulos, K. P., & Lubitz, C. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-13662-2_33 · Cited by 1
White, P. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-31107-4_25 · Cited by 1
Stowasser, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03980-5 · Cited by 1
A primer hyperaldosteronismus genetikája
Vékony, B., & Igaz, P. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32730 · Cited by 1
Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions
Tschernoster, N., Erger, F., Kohl, S., Reusch, B., Wenzel, A., Walsh, S., Thiele, H., Becker, C., Franitza, M., Bartram, M. P., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01215-1 · Cited by 1
Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
Young, W. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00014-1 · Cited by 2
Report on three cases of familial primary aldosteronism type IV
Zhang, W., Li, Q.-Y., Guo, Z., Zhang, C., Zhou, M.-S., & Zhao, Y. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003786 · Cited by 2
Genetics and Hypertension: Which Information for Clinical Practice
Padmanabhan, S., & Dominiczak, A. F. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_33 · Cited by 1
Sluggish genes and hypertension
Jordan, J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328312c0fa · Cited by 1
Endocrine causes of systemic hypertension in children and adolescents: a clinical review
Patel, D., Kamboj, Gupta, & Torres (2011) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s15789 · Cited by 2
Comiter, C. V., Capelouto, C. C., Tobin, M. S., Dluhy, R. G., & Richie, J. P. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67088-5 · Cited by 1
Self-citationGenetics of Benign Adrenocortical Tumors
Hannah‐Shmouni, F., & Stratakis, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_3 · Cited by 1
Genetic aspects of primary hyperaldosteronism and pheochromocytoma
Ворохобина, Н. В., Борисович, Ш. С., Александровна, Б. К., & Камильевна, Г. Р. (2017) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2017-23-3-178-185 · Cited by 1
Potassium Channel Mutations and Human Disease
Stowasser, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00041-5 · Cited by 1
Mineralocorticoid Disorders and Endocrine Hypertension
Cooke, D. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_16 · Cited by 1
Ehret, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00006-8 · Cited by 4
Applications of Genetics in Endocrinology
Jameson, J. L., & Kopp, P. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00004-4 · Cited by 3
Disorders of renal NaCl transport and implications for blood pressure regulation
Hennings, J. C., & Hübner, C. A. (2019) · Medizinische Genetik · doi:10.1007/s11825-019-0232-8 · Cited by 1
Primärer Hyperaldosteronismus: Genetik und Pathologie
Scholl, U. I. (2019) · Der Pathologe · doi:10.1007/s00292-019-00682-x · Cited by 2
A rare case of hyporeninemic hypertension: Answers
Mashmoushi, A. K., Choudhary, A., Thomas, C. P., & Wolf, M. T. F. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04667-4 · Cited by 1
Evaluation and Management of Hypertension in Children
Larkins, N., Lurbe, E., & Flynn, J. T. (2021) · Springer eBooks · doi:10.1007/978-3-642-27843-3_123-1 · Cited by 1
Progrès récents dans la génétique de l’hyperaldostéronisme primaire
Zennaro, M., Fernandes-Rosa, F. L., & Boulkroun, S. (2015) · médecine/sciences · doi:10.1051/medsci/20153104013 · Cited by 1
Rossi, G. P. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_4 · Cited by 1
Monogenic and Polygenic Contributions to Hypertension
Ingelfinger, J. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-31107-4_6 · Cited by 2
Pathophysiology and Mechanisms of Hypertension (Asian Context)
MERCADO-ASIS, L. B. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-95734-6_2 · Cited by 1
Advances in Medical Treatment of Primary Aldosteronism
Li, Y., Ji, Z.-G., & Wen, J. (2023) · Chinese Medical Sciences Journal · doi:10.24920/004137 · Cited by 1
Monogenic hypertension: an overview
Fernandez, C. J., Pappachan, J. M., & Scholl, U. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00023-6 · Cited by 2
Pappachan, J. M., Fernandez, C. J., & Geller, D. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00016-9 · Cited by 1
Pediatric Endocrine Hypertension Related to the Adrenal Glands
Kim, H. Y., & Kim, J. H. (2023) · Ewha Medical Journal · doi:10.12771/emj.2023.e30 · Cited by 1
Secondary Hypertension: Adrenal and Nervous Systems
Bravo, E. L. (2003) · doi:10.1007/978-1-4615-6493-5_6 · Cited by 1
von Wowern, F. (2006) · Lund University Publications (Lund University) · Cited by 3
Genetics of cardiovascular disease: a candidate gene study of USF1
Kristiansson, K. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 3
Potassium and Aldosterone Secretion in Glucocorticoid-Remediable Aldosteronisme
Ganguly, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4466-5 · Cited by 1
Schirpenbach, C., Seiler, L., Beuschlein, F., & Reincke, M. (2004) · Journal of Laboratory Medicine · doi:10.1515/labmed.2004.022 · Cited by 1
Identifying the genetic determinants of hypertension
Luft, F. C., & Sharma, A. M. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00190341 · Cited by 1
Adrenal-Dependent Hypertension
Young, W. F. (2003) · Problems in General Surgery · doi:10.1097/00013452-200309000-00009 · Cited by 1
Hereditary disorders of potassium homeostasis
Warnock, D. G. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00048-4 · Cited by 1
Overview of Mineralocorticoid Excess Syndromes
Gordon, R. D., & Stowasser, M. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_11 · Cited by 1
Activity of 5′-deletion mutants of the human CYP11B1 promoter in H295R cells
Lenz, D., & Bernhardt, R. (1996) · Endocrine Research · doi:10.1080/07435809609043738 · Cited by 1
[Glucocorticoid-remediable aldosteronism (GRA)].
Ando, K. (2000) · PubMed · Cited by 1
Harrap, S. B. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50095-8 · Cited by 2
Genetics of Familial Hyperaldosteronism
Monticone, S., Tetti, M., Losano, I., Veglio, F., & Mulatero, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64319-2 · Cited by 1
Álvarez, J., & Lurbe, E. (2008) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(08)71772-0 · Cited by 6
Clinical Syndromes of Metabolic Alkalosis
Moe, O. W., Seldin, D. W., & Alpern, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50061-9 · Cited by 1
Hensen, J., & Oelkers, W. (1997) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03045082 · Cited by 1
The Adrenal Cortex and its Disorders
Miller, W. L. (2005) · Wiley eBooks · doi:10.1002/9780470987117.ch15 · Cited by 4
Hanstein, B. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57533-4_14 · Cited by 1
Vagal involvement in non-dipping phenotype of Hsd11b2 knockout ratsPreprint
Mullins, L. J., Koutraki, Y. G., Bailey, M. A., & Mullins, J. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.11.480066 · Cited by 1
Koike, G., & Jacob, H. J. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_16 · Cited by 1
Witköwski, R., Prokop, O., & Ullrich, E. (1995) · Springer eBooks · doi:10.1007/978-3-642-97628-5_5 · Cited by 1
Capricchione, A., Winer, N., & Sowers, J. R. (2006) · Current Urology Reports · doi:10.1007/s11934-006-0045-6 · Cited by 1
Molekulargenetische Grundlagen
Konrad, M. (2002) · Springer eBooks · doi:10.1007/978-3-642-56378-2_12 · Cited by 1
Kandidatengene der arteriellen Hypertonie und ihre klinische Bedeutung
Schunkert, H. (1998) · Springer eBooks · doi:10.1007/978-3-642-80360-4_10
Molecular genetic basis of uremia
Födinger, M., & Sunder–Plassmann, G. (2004) · Springer eBooks · doi:10.1007/978-1-4020-2275-3_1
Genetica dell'iperaldosteronismo primitivo
Spoto, B., Gervasi, A., Bresolin, G., & Zoccali, C. (2004)
Molecular Biology of Cerebrovascular Diseases
Günel, M., Awad, I. A., & Lifton, R. P. (1998) · Springer eBooks · doi:10.1007/978-1-4613-9350-4_15
Self-citationMineralocorticoid Biosynthetic Pathways and Hypertension
Gómez-Sánchez, C. E. (1998) · Endocrine updates · doi:10.1007/978-1-4615-5569-8_16
Genetica e ipertensione arteriosa: forme monogeniche
Fortunato, M., Caruso, S., Vecchio, L. D., Procaccio, M., Tedoldi, S., Vigano, S. D. M. M., & Cusi, D. (2006)
Costa, M. H. S. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-11092007-134837
敏郎, 藤. (1998) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.87.suppl_117
Böttner, B., Cao, P., & Bernhardt, R. (1998) · Springer eBooks · doi:10.1007/978-4-431-68476-3_27
Benos, D. J. (1999) · Current topics in membranes · doi:10.1016/s0070-2161(08)60967-3
Stowasser, M. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/01070-2
La genetica dell’ipertensione arteriosa a bassa renina
Opocher, G., Sartorato, P., Mattarello, M. J., & Mantero, F. (2008) · L Endocrinologo · doi:10.1007/bf03344610
Schulte, P. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7876 · Cited by 1
Chapter 7 Cerebrovascular Disease
Penix, L. P., & Lanska, D. J. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60027-9
Physical activity, inherited characteristics, and hypertension
Hernelahti, M. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 2
Genetic Predisposition to Hypertension and Cardiovascular Disease
Ogihara, T., Katsuya, T., & Higaki, J. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4419-9232-1_11
Adrenal Insufficiency and Adrenal Cancer
Alexander, E. K., & Dluhy, R. G. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-277-7_8
Self-citationPérez, S. C., Alvarado, J. R. B., & Pérez, J. C. R. (2000) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(00)71095-6 · Cited by 1
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.